Research and Development

Showing 15 posts of 9599 posts found.

mouse

Number of UK animal testing procedures falls to lowest level since 2007

July 19, 2019 Medical Communications, Research and Development Animal testing, UK, drug development, pharma, rresearch

A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 19, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMAL Therapeutics, Alzheimer's Ebola, Amgen, AstraZeneca, EMA, FDA, Novartis, pharma

On 12 July news broke that Novartis, Amgen and Banner’s Alzheimer’s Institute were discontinuing a trial into investigational compound CNP520 …
johnmchutchison3x

Dr John McHutchinson steps down from Gilead with $1.1 million goodbye

July 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Gilead has said that Dr John McHutchison is stepping down after nine years at the firm. Gilead’s Chief Scientific Officer …
pixnio-drone

Autonomous drone successfully delivers temperature-controlled drugs in test programme

July 17, 2019 Research and Development, Sales and Marketing Drones, humanitarian aid, pharma

A humanitarian consortium has successfully completed a testing programme for the delivery of temperature-controlled medicines via the use of unmanned …

NICE greenlights Novartis Kisqali combo in HR+/HER2- advanced breast cancer

July 17, 2019 Manufacturing and Production, Medical Communications, Research and Development Cancer, Kisqali, NICE, Novartis, UK, breast cancer, pharma

Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (CDK4/6) …
roche

Roche signs deal with Skyhawk over molecules that modulate RNA splicing

July 17, 2019 Research and Development Genentech, Roche, Skyhawk, drug development, rna splicing

Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that modulate …
genentech_web

Genentech signs $1 billion deal with Sosei over GCPRs

July 17, 2019 Research and Development Genentech, Roche, gcprs, pharma, sosei

Roche’s Genentech has entered into a partnership with Sosei Heptares to develop small molecules and biologics that G protein-coupled receptor …
astrazeneca_plaque

AstraZeneca to switch entire fleet to electric vehicles by 2030

July 17, 2019 Research and Development AstraZeneca, EV100, electric vehicles, environmentalism, pharma, renewables

AstraZeneca has revealed plans to use only electric vehicles by 2030. In joining the EV100 group, AstraZeneca will transfer the …
shutterstock_159488225

Capricor’s share price rockets up by 150% on Phase 2 Duchenne muscular dystrophy success

July 16, 2019 Manufacturing and Production, Research and Development CAP-1002, Capricor Therapeutics, Duchenne Muscular Dystrophy, pharma

Capricor Therapeutics has unveiled impactful new Phase 2 data for its investigational allogeneic cardiosphere-derived cell therapy CAP-1002 in the treatment …
darius_hughes

Darius Hughes, Head of Vaccines Business Unit UK, Pfizer

July 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Darius Hughes, Pfizer, Working Life, biotech, pharma, vaccines

“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” – Darius Hughes, Head …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HPV, NHS, NICE, Novartis, Pfizer, Trump, pharma, vaccines

This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the …
shutterstock_45634132_0

African measles cases surge by 700%

July 11, 2019 Medical Communications, Research and Development Africa, Médecins Sans Frontières, measles, pharma

The number of cases of measles infection on the African continent has surged by 700%, according to data from the …
neurons-3743011_960_720

Biohaven’s CGPR antagonist migraine treatment beats placebo in Phase 3 trial

July 11, 2019 Research and Development Biohaven, CGPR, clinical trials, headache, migraine, pharma

Connecticut-based firm Biohaven has said its migraine drug rimegepant showed superiority over placebo in a Phase 3 clinical trial. The …

Biocon founders donate £6 million to Glasgow University for new research hub

July 10, 2019 Research and Development

The founders of Biocon India have donated £6 million ($7.5 million) to Glasgow University. John Shaw and his wife Kiran …
The Gateway to Local Adoption Series

Latest content